| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| cdc25 Phosphatases | 26 | 2011 | 100 | 3.690 |
Why?
|
| Protein Kinases | 38 | 2012 | 888 | 3.160 |
Why?
|
| Cell Cycle Proteins | 34 | 2012 | 2099 | 2.010 |
Why?
|
| Triple Negative Breast Neoplasms | 10 | 2023 | 1295 | 1.760 |
Why?
|
| Tyrosine 3-Monooxygenase | 14 | 2004 | 83 | 1.690 |
Why?
|
| Intestine, Small | 7 | 2021 | 514 | 1.650 |
Why?
|
| CDC2 Protein Kinase | 23 | 2001 | 180 | 1.540 |
Why?
|
| Cell Polarity | 7 | 2013 | 220 | 1.360 |
Why?
|
| Cell Cycle | 25 | 2019 | 2115 | 1.330 |
Why?
|
| Tumor Suppressor Protein p53 | 13 | 2019 | 3620 | 1.330 |
Why?
|
| DNA Damage | 23 | 2019 | 1987 | 1.330 |
Why?
|
| Checkpoint Kinase 1 | 20 | 2019 | 180 | 1.230 |
Why?
|
| Fasting | 3 | 2021 | 356 | 1.230 |
Why?
|
| Stem Cells | 6 | 2019 | 1243 | 1.220 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 4 | 2013 | 531 | 1.140 |
Why?
|
| Phosphorylation | 67 | 2019 | 4885 | 1.130 |
Why?
|
| Protein-Tyrosine Kinases | 22 | 2008 | 1787 | 1.050 |
Why?
|
| Serine | 14 | 2018 | 389 | 1.040 |
Why?
|
| HeLa Cells | 30 | 2019 | 1653 | 0.990 |
Why?
|
| 14-3-3 Proteins | 20 | 2019 | 143 | 0.950 |
Why?
|
| Mitosis | 14 | 2004 | 623 | 0.910 |
Why?
|
| Nuclear Proteins | 15 | 2021 | 3384 | 0.900 |
Why?
|
| Xenograft Model Antitumor Assays | 11 | 2024 | 3930 | 0.860 |
Why?
|
| G2 Phase | 13 | 2009 | 213 | 0.810 |
Why?
|
| Epithelial Cells | 5 | 2018 | 1848 | 0.800 |
Why?
|
| Animals | 95 | 2024 | 60938 | 0.770 |
Why?
|
| Cyclins | 12 | 1999 | 466 | 0.750 |
Why?
|
| Radiation Tolerance | 3 | 2019 | 635 | 0.730 |
Why?
|
| Baculoviridae | 13 | 2018 | 86 | 0.730 |
Why?
|
| Breast Neoplasms | 17 | 2024 | 16049 | 0.700 |
Why?
|
| Proteins | 17 | 2018 | 1985 | 0.680 |
Why?
|
| Tumor Escape | 1 | 2021 | 253 | 0.680 |
Why?
|
| Ubiquitin-Protein Ligases | 5 | 2013 | 867 | 0.680 |
Why?
|
| Mice | 51 | 2024 | 35280 | 0.650 |
Why?
|
| Proliferating Cell Nuclear Antigen | 3 | 2015 | 199 | 0.650 |
Why?
|
| Colony-Forming Units Assay | 1 | 2018 | 245 | 0.640 |
Why?
|
| Duodenum | 1 | 2019 | 154 | 0.630 |
Why?
|
| Staurosporine | 6 | 2012 | 144 | 0.620 |
Why?
|
| Neoplasm Metastasis | 4 | 2018 | 5238 | 0.620 |
Why?
|
| Protein Kinase C | 4 | 2008 | 397 | 0.610 |
Why?
|
| Spheroids, Cellular | 1 | 2018 | 217 | 0.610 |
Why?
|
| Gene Expression Regulation | 14 | 2021 | 4067 | 0.610 |
Why?
|
| Immediate-Early Proteins | 2 | 2016 | 109 | 0.600 |
Why?
|
| Organ Sparing Treatments | 1 | 2019 | 279 | 0.590 |
Why?
|
| Threonine | 7 | 2007 | 165 | 0.590 |
Why?
|
| DNA Replication | 16 | 2019 | 753 | 0.580 |
Why?
|
| Adiposity | 2 | 2010 | 241 | 0.570 |
Why?
|
| Radiation-Sensitizing Agents | 1 | 2018 | 370 | 0.550 |
Why?
|
| Protein Binding | 18 | 2016 | 3480 | 0.530 |
Why?
|
| Mice, SCID | 6 | 2021 | 1864 | 0.520 |
Why?
|
| Camptothecin | 4 | 2012 | 535 | 0.520 |
Why?
|
| Breast | 2 | 2021 | 1361 | 0.510 |
Why?
|
| Tyrosine | 14 | 1994 | 508 | 0.500 |
Why?
|
| Doxorubicin | 2 | 2019 | 3059 | 0.500 |
Why?
|
| Cell Line, Tumor | 24 | 2024 | 14850 | 0.490 |
Why?
|
| Protein Kinase Inhibitors | 6 | 2012 | 4884 | 0.490 |
Why?
|
| Luciferases, Firefly | 2 | 2011 | 39 | 0.480 |
Why?
|
| Multienzyme Complexes | 2 | 2007 | 222 | 0.480 |
Why?
|
| Cell Cycle Checkpoints | 2 | 2012 | 278 | 0.470 |
Why?
|
| Hepatocytes | 2 | 2013 | 353 | 0.470 |
Why?
|
| Schizosaccharomyces | 7 | 1999 | 119 | 0.460 |
Why?
|
| Carcinoma, Intraductal, Noninfiltrating | 1 | 2018 | 694 | 0.450 |
Why?
|
| Phosphoserine | 10 | 2013 | 109 | 0.450 |
Why?
|
| Genetic Vectors | 11 | 2013 | 1712 | 0.440 |
Why?
|
| Cell Division | 5 | 2010 | 2554 | 0.440 |
Why?
|
| Schizosaccharomyces pombe Proteins | 11 | 1999 | 85 | 0.440 |
Why?
|
| Cyclin B | 5 | 2008 | 67 | 0.440 |
Why?
|
| Forkhead Transcription Factors | 2 | 2016 | 769 | 0.420 |
Why?
|
| Cell Proliferation | 5 | 2019 | 7300 | 0.420 |
Why?
|
| Exodeoxyribonucleases | 3 | 2019 | 106 | 0.410 |
Why?
|
| Mice, Inbred C57BL | 11 | 2021 | 7154 | 0.400 |
Why?
|
| Cyclin-Dependent Kinases | 7 | 2003 | 321 | 0.400 |
Why?
|
| BRCA1 Protein | 4 | 2024 | 517 | 0.390 |
Why?
|
| Phosphoprotein Phosphatases | 5 | 2006 | 217 | 0.390 |
Why?
|
| Molecular Sequence Data | 32 | 2014 | 6123 | 0.380 |
Why?
|
| Thiophenes | 1 | 2012 | 151 | 0.380 |
Why?
|
| Humans | 102 | 2024 | 270442 | 0.370 |
Why?
|
| Urea | 1 | 2012 | 290 | 0.370 |
Why?
|
| Ubiquitin | 4 | 2010 | 342 | 0.370 |
Why?
|
| Gangliosides | 2 | 2021 | 110 | 0.370 |
Why?
|
| Casein Kinase Ialpha | 1 | 2010 | 16 | 0.360 |
Why?
|
| Antineoplastic Agents | 10 | 2020 | 14501 | 0.360 |
Why?
|
| Female | 41 | 2024 | 147064 | 0.360 |
Why?
|
| DNA Breaks, Double-Stranded | 3 | 2019 | 330 | 0.360 |
Why?
|
| Cells, Cultured | 18 | 2018 | 5663 | 0.360 |
Why?
|
| S Phase | 6 | 2017 | 285 | 0.350 |
Why?
|
| Gluconeogenesis | 1 | 2010 | 127 | 0.350 |
Why?
|
| Signal Transduction | 19 | 2021 | 12133 | 0.350 |
Why?
|
| Ubiquitination | 4 | 2018 | 579 | 0.350 |
Why?
|
| Recombinant Proteins | 15 | 2019 | 2941 | 0.340 |
Why?
|
| Cell Line | 29 | 2008 | 5127 | 0.340 |
Why?
|
| Amino Acid Sequence | 26 | 2007 | 4278 | 0.340 |
Why?
|
| DNA Repair | 7 | 2019 | 1906 | 0.330 |
Why?
|
| Mice, Knockout | 11 | 2019 | 5793 | 0.330 |
Why?
|
| Promoter Regions, Genetic | 3 | 2021 | 3105 | 0.330 |
Why?
|
| Gene Expression | 8 | 2021 | 3593 | 0.330 |
Why?
|
| Mutagenesis, Site-Directed | 10 | 2008 | 620 | 0.330 |
Why?
|
| Tumor Suppressor Proteins | 4 | 2016 | 1876 | 0.320 |
Why?
|
| Radiation-Protective Agents | 2 | 2019 | 129 | 0.320 |
Why?
|
| Cloning, Molecular | 11 | 2004 | 1226 | 0.320 |
Why?
|
| Radiation, Ionizing | 6 | 2011 | 191 | 0.320 |
Why?
|
| Fatty Liver | 1 | 2010 | 250 | 0.310 |
Why?
|
| Molecular Targeted Therapy | 3 | 2020 | 2371 | 0.310 |
Why?
|
| Recombinant Fusion Proteins | 19 | 2004 | 1595 | 0.310 |
Why?
|
| Mice, Inbred NOD | 4 | 2020 | 902 | 0.300 |
Why?
|
| Enzyme Activation | 11 | 2017 | 1798 | 0.300 |
Why?
|
| Histones | 4 | 2021 | 1493 | 0.300 |
Why?
|
| Checkpoint Kinase 2 | 10 | 2008 | 130 | 0.300 |
Why?
|
| Gene Deletion | 2 | 2011 | 1472 | 0.290 |
Why?
|
| Glycogen Synthase Kinase 3 | 1 | 2008 | 161 | 0.290 |
Why?
|
| Radiation Injuries | 3 | 2019 | 1449 | 0.290 |
Why?
|
| Protein Processing, Post-Translational | 5 | 2015 | 802 | 0.290 |
Why?
|
| Interphase | 3 | 2004 | 145 | 0.280 |
Why?
|
| Disease Models, Animal | 6 | 2020 | 7414 | 0.280 |
Why?
|
| Phthalazines | 2 | 2019 | 260 | 0.270 |
Why?
|
| DNA-Binding Proteins | 9 | 2010 | 4907 | 0.270 |
Why?
|
| Alternative Splicing | 2 | 2020 | 595 | 0.270 |
Why?
|
| Gene Expression Regulation, Viral | 2 | 2001 | 188 | 0.260 |
Why?
|
| Epithelial-Mesenchymal Transition | 3 | 2020 | 991 | 0.260 |
Why?
|
| Carrier Proteins | 6 | 2021 | 2054 | 0.260 |
Why?
|
| Alkaloids | 3 | 2001 | 80 | 0.260 |
Why?
|
| Drug Resistance, Neoplasm | 3 | 2019 | 5292 | 0.260 |
Why?
|
| Apoptosis | 7 | 2019 | 7755 | 0.260 |
Why?
|
| Flap Endonucleases | 2 | 2015 | 27 | 0.260 |
Why?
|
| Pancreatic Neoplasms | 3 | 2019 | 5227 | 0.260 |
Why?
|
| Insulin Resistance | 2 | 2010 | 744 | 0.250 |
Why?
|
| Energy Metabolism | 2 | 2010 | 1007 | 0.250 |
Why?
|
| Heterografts | 4 | 2020 | 749 | 0.250 |
Why?
|
| 3-Hydroxybutyric Acid | 2 | 2021 | 33 | 0.250 |
Why?
|
| AMP-Activated Protein Kinases | 4 | 2019 | 409 | 0.240 |
Why?
|
| Base Sequence | 14 | 2010 | 4929 | 0.240 |
Why?
|
| Metformin | 2 | 2019 | 390 | 0.240 |
Why?
|
| Neoplasms | 6 | 2018 | 15697 | 0.240 |
Why?
|
| Neoplastic Stem Cells | 3 | 2021 | 1469 | 0.240 |
Why?
|
| Cell Survival | 4 | 2019 | 3061 | 0.230 |
Why?
|
| Gene Expression Regulation, Neoplastic | 5 | 2021 | 9064 | 0.230 |
Why?
|
| Endoplasmic Reticulum | 3 | 2018 | 317 | 0.230 |
Why?
|
| Poly(ADP-ribose) Polymerase Inhibitors | 3 | 2024 | 503 | 0.230 |
Why?
|
| Antigens, Polyomavirus Transforming | 7 | 2002 | 110 | 0.230 |
Why?
|
| Ketone Bodies | 2 | 2021 | 56 | 0.220 |
Why?
|
| Blotting, Western | 7 | 2015 | 3595 | 0.220 |
Why?
|
| HEK293 Cells | 6 | 2020 | 1512 | 0.220 |
Why?
|
| Plasmids | 5 | 2012 | 843 | 0.210 |
Why?
|
| Golgi Apparatus | 2 | 2008 | 145 | 0.210 |
Why?
|
| Cysteine Endopeptidases | 1 | 2003 | 255 | 0.210 |
Why?
|
| Chromatin | 6 | 2021 | 972 | 0.210 |
Why?
|
| Neoplasm Proteins | 4 | 2012 | 3288 | 0.200 |
Why?
|
| Cell Nucleus | 8 | 2015 | 1642 | 0.200 |
Why?
|
| Maximum Tolerated Dose | 2 | 2019 | 1314 | 0.200 |
Why?
|
| CDC2-CDC28 Kinases | 4 | 1994 | 129 | 0.200 |
Why?
|
| Insulin | 2 | 2009 | 1474 | 0.200 |
Why?
|
| Immunoprecipitation | 2 | 2013 | 590 | 0.200 |
Why?
|
| Adipose Tissue | 1 | 2007 | 775 | 0.200 |
Why?
|
| Active Transport, Cell Nucleus | 2 | 2006 | 320 | 0.190 |
Why?
|
| Glutamine | 2 | 2021 | 303 | 0.190 |
Why?
|
| Glutathione Transferase | 8 | 2015 | 367 | 0.190 |
Why?
|
| Cullin Proteins | 2 | 2012 | 40 | 0.190 |
Why?
|
| RNA, Small Interfering | 5 | 2016 | 2221 | 0.190 |
Why?
|
| Gene Expression Regulation, Enzymologic | 2 | 1994 | 696 | 0.180 |
Why?
|
| Single-Cell Analysis | 2 | 2021 | 523 | 0.180 |
Why?
|
| Cyclin-Dependent Kinase 2 | 5 | 2017 | 249 | 0.180 |
Why?
|
| Drug Repositioning | 1 | 2020 | 55 | 0.180 |
Why?
|
| Quinuclidines | 1 | 2020 | 48 | 0.180 |
Why?
|
| Transfection | 10 | 2004 | 2988 | 0.180 |
Why?
|
| Radiation Protection | 2 | 2019 | 207 | 0.180 |
Why?
|
| Phosphotransferases (Alcohol Group Acceptor) | 2 | 2019 | 131 | 0.180 |
Why?
|
| Proteome | 1 | 2004 | 577 | 0.180 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2001 | 130 | 0.180 |
Why?
|
| Carcinosarcoma | 1 | 2021 | 146 | 0.180 |
Why?
|
| DNA, Fungal | 2 | 1999 | 130 | 0.180 |
Why?
|
| A Kinase Anchor Proteins | 1 | 2020 | 25 | 0.180 |
Why?
|
| Models, Biological | 8 | 2013 | 3254 | 0.180 |
Why?
|
| Substrate Specificity | 9 | 2006 | 559 | 0.170 |
Why?
|
| Neoplasm Transplantation | 2 | 2020 | 1532 | 0.170 |
Why?
|
| Small Molecule Libraries | 1 | 2021 | 196 | 0.170 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 2 | 2016 | 343 | 0.170 |
Why?
|
| Crosses, Genetic | 2 | 2010 | 243 | 0.170 |
Why?
|
| Protein Transport | 4 | 2013 | 745 | 0.170 |
Why?
|
| B-Lymphocytes | 3 | 2009 | 1347 | 0.170 |
Why?
|
| Proof of Concept Study | 1 | 2019 | 56 | 0.170 |
Why?
|
| Interleukin-17 | 1 | 2021 | 264 | 0.170 |
Why?
|
| Phosphofructokinase-2 | 1 | 2019 | 38 | 0.170 |
Why?
|
| Cyclin B1 | 5 | 2008 | 59 | 0.170 |
Why?
|
| DNA Primers | 4 | 2010 | 1421 | 0.170 |
Why?
|
| Mercaptoethylamines | 1 | 2019 | 4 | 0.170 |
Why?
|
| Genes, Viral | 4 | 1990 | 201 | 0.170 |
Why?
|
| beta-Transducin Repeat-Containing Proteins | 2 | 2010 | 41 | 0.170 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2019 | 232 | 0.170 |
Why?
|
| Sequence Homology, Amino Acid | 5 | 2007 | 1006 | 0.170 |
Why?
|
| Nanotubes, Carbon | 1 | 2019 | 30 | 0.170 |
Why?
|
| Genes, Neoplasm | 1 | 2020 | 328 | 0.170 |
Why?
|
| Hypoxia-Inducible Factor-Proline Dioxygenases | 1 | 2019 | 50 | 0.170 |
Why?
|
| High-Throughput Screening Assays | 1 | 2020 | 214 | 0.160 |
Why?
|
| Metaplasia | 1 | 2020 | 388 | 0.160 |
Why?
|
| G1 Phase | 4 | 2009 | 293 | 0.160 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 5 | 2023 | 16258 | 0.160 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinase Kinase | 1 | 2019 | 60 | 0.160 |
Why?
|
| Transcription Factors | 4 | 2021 | 5361 | 0.160 |
Why?
|
| Isoquinolines | 1 | 2019 | 119 | 0.160 |
Why?
|
| Precipitin Tests | 4 | 2004 | 336 | 0.160 |
Why?
|
| Amifostine | 1 | 2019 | 97 | 0.160 |
Why?
|
| Blood Glucose | 2 | 2021 | 1269 | 0.160 |
Why?
|
| Obesity | 2 | 2010 | 2992 | 0.150 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2021 | 505 | 0.150 |
Why?
|
| Etoposide | 2 | 2015 | 886 | 0.150 |
Why?
|
| Male | 18 | 2021 | 127418 | 0.150 |
Why?
|
| DNA Repair Enzymes | 1 | 2019 | 238 | 0.150 |
Why?
|
| Random Allocation | 1 | 2019 | 717 | 0.150 |
Why?
|
| Wnt Signaling Pathway | 1 | 2020 | 446 | 0.150 |
Why?
|
| Diet, High-Fat | 1 | 2019 | 250 | 0.150 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p18 | 1 | 2017 | 53 | 0.150 |
Why?
|
| Drug Carriers | 1 | 2019 | 332 | 0.150 |
Why?
|
| Autoimmune Diseases | 1 | 2001 | 418 | 0.150 |
Why?
|
| Genes, Reporter | 3 | 2013 | 809 | 0.150 |
Why?
|
| Embryonic Development | 2 | 2010 | 315 | 0.150 |
Why?
|
| Antineoplastic Agents, Phytogenic | 2 | 2012 | 881 | 0.150 |
Why?
|
| Abdomen | 1 | 2019 | 337 | 0.150 |
Why?
|
| Oncogene Protein pp60(v-src) | 4 | 1991 | 18 | 0.140 |
Why?
|
| Adenoviridae | 3 | 2013 | 1455 | 0.140 |
Why?
|
| Coculture Techniques | 1 | 2018 | 632 | 0.140 |
Why?
|
| Kinetics | 8 | 2012 | 2098 | 0.140 |
Why?
|
| Neutrophils | 1 | 2021 | 845 | 0.140 |
Why?
|
| Glycine | 1 | 2019 | 305 | 0.140 |
Why?
|
| Proteomics | 1 | 2004 | 1422 | 0.140 |
Why?
|
| DNA | 7 | 2015 | 2742 | 0.140 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 395 | 0.140 |
Why?
|
| Regeneration | 1 | 2019 | 288 | 0.140 |
Why?
|
| Time Factors | 6 | 2019 | 13251 | 0.130 |
Why?
|
| Vesicular stomatitis Indiana virus | 3 | 1985 | 24 | 0.130 |
Why?
|
| Organs at Risk | 1 | 2019 | 548 | 0.130 |
Why?
|
| Poly Adenosine Diphosphate Ribose | 1 | 2015 | 10 | 0.130 |
Why?
|
| Mice, Transgenic | 5 | 2021 | 4229 | 0.130 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2016 | 159 | 0.130 |
Why?
|
| Alleles | 2 | 2013 | 2479 | 0.130 |
Why?
|
| RNA, Messenger | 7 | 2011 | 6221 | 0.130 |
Why?
|
| Profilins | 1 | 2015 | 2 | 0.130 |
Why?
|
| Homeostasis | 2 | 2011 | 946 | 0.120 |
Why?
|
| Tumor Burden | 1 | 2021 | 2018 | 0.120 |
Why?
|
| Subcellular Fractions | 1 | 2015 | 200 | 0.120 |
Why?
|
| Peptide Mapping | 7 | 1995 | 112 | 0.120 |
Why?
|
| Protein Structure, Tertiary | 4 | 2015 | 1503 | 0.120 |
Why?
|
| CTLA-4 Antigen | 1 | 2018 | 665 | 0.120 |
Why?
|
| Enzyme Inhibitors | 3 | 2017 | 1937 | 0.120 |
Why?
|
| Receptors, Laminin | 1 | 2013 | 13 | 0.120 |
Why?
|
| Gene Knock-In Techniques | 2 | 2011 | 177 | 0.120 |
Why?
|
| Spodoptera | 6 | 2004 | 61 | 0.120 |
Why?
|
| Liver | 2 | 2013 | 2989 | 0.120 |
Why?
|
| Cisplatin | 2 | 2017 | 2456 | 0.120 |
Why?
|
| Protein Tyrosine Phosphatases | 5 | 1998 | 185 | 0.110 |
Why?
|
| Hypoglycemic Agents | 1 | 2018 | 609 | 0.110 |
Why?
|
| Cell Communication | 2 | 2014 | 506 | 0.110 |
Why?
|
| Food Deprivation | 1 | 2013 | 47 | 0.110 |
Why?
|
| Polyomavirus | 3 | 1990 | 30 | 0.110 |
Why?
|
| Luminescence | 1 | 2013 | 45 | 0.110 |
Why?
|
| Polymerase Chain Reaction | 5 | 2011 | 3234 | 0.110 |
Why?
|
| Laminin | 1 | 2013 | 201 | 0.110 |
Why?
|
| Interferon Type I | 1 | 2014 | 261 | 0.110 |
Why?
|
| Insect Viruses | 2 | 1990 | 9 | 0.110 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2018 | 999 | 0.110 |
Why?
|
| Phosphopeptides | 5 | 2006 | 67 | 0.110 |
Why?
|
| Mutation | 14 | 2019 | 15579 | 0.110 |
Why?
|
| Forkhead Box Protein O1 | 1 | 2013 | 163 | 0.110 |
Why?
|
| T-Lymphocytes | 4 | 2001 | 3955 | 0.110 |
Why?
|
| Cell Fractionation | 1 | 2012 | 68 | 0.110 |
Why?
|
| Moths | 4 | 2001 | 36 | 0.110 |
Why?
|
| Calcium | 1 | 2019 | 1556 | 0.110 |
Why?
|
| Proto-Oncogene Proteins | 9 | 2005 | 2547 | 0.110 |
Why?
|
| Aromatase | 1 | 2012 | 57 | 0.100 |
Why?
|
| Xenopus | 6 | 2015 | 226 | 0.100 |
Why?
|
| Epithelium | 1 | 2014 | 729 | 0.100 |
Why?
|
| Neoadjuvant Therapy | 3 | 2023 | 5105 | 0.100 |
Why?
|
| Mammography | 1 | 2018 | 1030 | 0.100 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2017 | 412 | 0.100 |
Why?
|
| Viral Structural Proteins | 2 | 2004 | 49 | 0.100 |
Why?
|
| RNA Interference | 2 | 2019 | 1411 | 0.100 |
Why?
|
| Paclitaxel | 1 | 2019 | 2055 | 0.100 |
Why?
|
| Genes, cdc | 1 | 2012 | 83 | 0.100 |
Why?
|
| Mice, Nude | 4 | 2021 | 4343 | 0.100 |
Why?
|
| Telomere | 1 | 2015 | 527 | 0.100 |
Why?
|
| Radiotherapy | 1 | 2019 | 1852 | 0.100 |
Why?
|
| Phenotype | 4 | 2021 | 6395 | 0.100 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 4 | 2004 | 571 | 0.100 |
Why?
|
| Cyclophosphamide | 1 | 2019 | 3143 | 0.100 |
Why?
|
| B7-H1 Antigen | 1 | 2018 | 1057 | 0.100 |
Why?
|
| Antineoplastic Agents, Immunological | 1 | 2021 | 1313 | 0.100 |
Why?
|
| Hypothalamus | 1 | 2013 | 255 | 0.100 |
Why?
|
| Genes, erbB-2 | 1 | 2012 | 232 | 0.100 |
Why?
|
| Radiotherapy Dosage | 1 | 2019 | 3967 | 0.090 |
Why?
|
| Phosphatidylinositol 3-Kinases | 4 | 2020 | 1706 | 0.090 |
Why?
|
| Neoplastic Cells, Circulating | 1 | 2016 | 621 | 0.090 |
Why?
|
| Virus Diseases | 1 | 2014 | 400 | 0.090 |
Why?
|
| Genes, p53 | 2 | 2012 | 1122 | 0.090 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2015 | 1101 | 0.090 |
Why?
|
| Binding Sites | 7 | 2006 | 2208 | 0.090 |
Why?
|
| Starvation | 1 | 2010 | 27 | 0.090 |
Why?
|
| Transcriptome | 1 | 2019 | 1951 | 0.090 |
Why?
|
| Tetradecanoylphorbol Acetate | 3 | 2008 | 227 | 0.090 |
Why?
|
| Early Detection of Cancer | 1 | 2018 | 1334 | 0.090 |
Why?
|
| Stress, Physiological | 1 | 2013 | 501 | 0.090 |
Why?
|
| Gene Targeting | 2 | 2001 | 298 | 0.090 |
Why?
|
| Disease Progression | 1 | 2021 | 6887 | 0.090 |
Why?
|
| Cyclotrons | 2 | 2007 | 9 | 0.090 |
Why?
|
| Aromatase Inhibitors | 1 | 2012 | 312 | 0.090 |
Why?
|
| Microtubule-Organizing Center | 1 | 2009 | 9 | 0.090 |
Why?
|
| Dose-Response Relationship, Radiation | 2 | 2002 | 745 | 0.090 |
Why?
|
| Trans-Activators | 2 | 2004 | 1624 | 0.090 |
Why?
|
| Proto-Oncogene Proteins pp60(c-src) | 7 | 1992 | 98 | 0.090 |
Why?
|
| Fibroblasts | 4 | 2019 | 1689 | 0.080 |
Why?
|
| Intestinal Mucosa | 1 | 2015 | 1103 | 0.080 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2007 | 83 | 0.080 |
Why?
|
| DNA Helicases | 1 | 2012 | 451 | 0.080 |
Why?
|
| Piperazines | 2 | 2017 | 2130 | 0.080 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2011 | 472 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 3 | 2020 | 1082 | 0.080 |
Why?
|
| Retroviridae | 2 | 1987 | 323 | 0.080 |
Why?
|
| Immunoblotting | 4 | 2001 | 898 | 0.080 |
Why?
|
| Genotype | 2 | 2009 | 4167 | 0.080 |
Why?
|
| Lactams, Macrocyclic | 1 | 2009 | 93 | 0.080 |
Why?
|
| Benzoquinones | 1 | 2009 | 112 | 0.080 |
Why?
|
| Lung Neoplasms | 4 | 2020 | 11816 | 0.080 |
Why?
|
| Blastocyst | 1 | 2009 | 130 | 0.080 |
Why?
|
| Dietary Fats | 1 | 2010 | 351 | 0.080 |
Why?
|
| DNA, Complementary | 3 | 2004 | 880 | 0.080 |
Why?
|
| Tissue Distribution | 2 | 2019 | 907 | 0.080 |
Why?
|
| Genome, Human | 2 | 2018 | 1897 | 0.080 |
Why?
|
| Phosphothreonine | 1 | 2008 | 23 | 0.080 |
Why?
|
| Drosophila Proteins | 1 | 1994 | 884 | 0.080 |
Why?
|
| Antigens, Viral | 1 | 2010 | 473 | 0.080 |
Why?
|
| Insulin-Secreting Cells | 1 | 2009 | 165 | 0.080 |
Why?
|
| Cell Transformation, Viral | 2 | 1985 | 136 | 0.080 |
Why?
|
| Enzyme Stability | 1 | 2008 | 108 | 0.080 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 4442 | 0.080 |
Why?
|
| MAP Kinase Kinase Kinase 1 | 2 | 2012 | 43 | 0.080 |
Why?
|
| Receptors, Estrogen | 2 | 2012 | 2121 | 0.080 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2009 | 198 | 0.070 |
Why?
|
| Gammaherpesvirinae | 1 | 2007 | 12 | 0.070 |
Why?
|
| Glycogen Synthase Kinase 3 beta | 1 | 2008 | 166 | 0.070 |
Why?
|
| Retroviridae Proteins | 1 | 1987 | 20 | 0.070 |
Why?
|
| Tumor Microenvironment | 1 | 2018 | 2980 | 0.070 |
Why?
|
| Phosphotyrosine | 5 | 1998 | 121 | 0.070 |
Why?
|
| Transcriptional Activation | 1 | 2011 | 1096 | 0.070 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2007 | 37 | 0.070 |
Why?
|
| Membrane Proteins | 5 | 2000 | 2914 | 0.070 |
Why?
|
| Cytoplasm | 4 | 2006 | 652 | 0.070 |
Why?
|
| Genomics | 1 | 2018 | 2818 | 0.070 |
Why?
|
| Cytomegalovirus | 1 | 2010 | 481 | 0.070 |
Why?
|
| Genetic Complementation Test | 2 | 2004 | 131 | 0.070 |
Why?
|
| Ataxia Telangiectasia Mutated Proteins | 4 | 2001 | 434 | 0.070 |
Why?
|
| Metabolic Networks and Pathways | 2 | 2019 | 342 | 0.070 |
Why?
|
| Mitogen-Activated Protein Kinases | 3 | 2006 | 656 | 0.070 |
Why?
|
| Chromatography, Gel | 3 | 1994 | 155 | 0.070 |
Why?
|
| Receptors, Progesterone | 1 | 2012 | 1415 | 0.070 |
Why?
|
| DNA, Neoplasm | 1 | 2012 | 1929 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 4 | 2015 | 774 | 0.070 |
Why?
|
| Protein Phosphatase 2 | 1 | 2006 | 88 | 0.070 |
Why?
|
| RNA, Viral | 3 | 1985 | 690 | 0.070 |
Why?
|
| Carbazoles | 1 | 2006 | 88 | 0.070 |
Why?
|
| Peptides | 3 | 2004 | 1503 | 0.070 |
Why?
|
| Cell Membrane | 2 | 2008 | 861 | 0.070 |
Why?
|
| Cytomegalovirus Infections | 1 | 2010 | 463 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2012 | 1459 | 0.070 |
Why?
|
| Transcription, Genetic | 4 | 2015 | 3148 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-raf | 3 | 2001 | 83 | 0.060 |
Why?
|
| Saccharomyces cerevisiae Proteins | 2 | 2002 | 453 | 0.060 |
Why?
|
| Administration, Oral | 2 | 2019 | 1581 | 0.060 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2011 | 1266 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 3 | 2014 | 2506 | 0.060 |
Why?
|
| Insecta | 4 | 1993 | 75 | 0.060 |
Why?
|
| Chromatography | 1 | 2004 | 50 | 0.060 |
Why?
|
| Bacteria | 2 | 2003 | 623 | 0.060 |
Why?
|
| Protein Biosynthesis | 4 | 2018 | 913 | 0.060 |
Why?
|
| Hydroxyurea | 3 | 2001 | 212 | 0.060 |
Why?
|
| Histone Deacetylases | 1 | 2006 | 365 | 0.060 |
Why?
|
| Phosphoric Monoester Hydrolases | 2 | 2005 | 257 | 0.060 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 2004 | 570 | 0.060 |
Why?
|
| Virus Cultivation | 1 | 2004 | 71 | 0.060 |
Why?
|
| Nuclear Receptor Coactivators | 1 | 2024 | 88 | 0.060 |
Why?
|
| Amino Acid Motifs | 2 | 2002 | 412 | 0.060 |
Why?
|
| Gamma Rays | 2 | 2011 | 242 | 0.060 |
Why?
|
| Fluorescence | 1 | 2004 | 202 | 0.060 |
Why?
|
| TOR Serine-Threonine Kinases | 3 | 2023 | 1559 | 0.060 |
Why?
|
| Jurkat Cells | 2 | 2009 | 315 | 0.060 |
Why?
|
| Macromolecular Substances | 2 | 1994 | 298 | 0.060 |
Why?
|
| Phosphoproteins | 4 | 2007 | 1177 | 0.060 |
Why?
|
| Ovarian Neoplasms | 1 | 2019 | 4730 | 0.060 |
Why?
|
| RNA Caps | 1 | 1983 | 38 | 0.050 |
Why?
|
| Luciferases | 1 | 2004 | 454 | 0.050 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 2 | 2019 | 1375 | 0.050 |
Why?
|
| Escherichia coli | 2 | 2001 | 1220 | 0.050 |
Why?
|
| Protein Folding | 1 | 2004 | 289 | 0.050 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2009 | 1168 | 0.050 |
Why?
|
| RNA, Antisense | 1 | 2002 | 69 | 0.050 |
Why?
|
| Protein Interaction Mapping | 1 | 2003 | 167 | 0.050 |
Why?
|
| Phosphotransferases | 3 | 1992 | 82 | 0.050 |
Why?
|
| In Vitro Techniques | 3 | 1994 | 1637 | 0.050 |
Why?
|
| Pilot Projects | 2 | 2019 | 2858 | 0.050 |
Why?
|
| Cell Separation | 1 | 2004 | 598 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 1 | 2017 | 4072 | 0.050 |
Why?
|
| Arsenites | 1 | 2002 | 20 | 0.050 |
Why?
|
| Catalytic Domain | 1 | 2003 | 307 | 0.050 |
Why?
|
| Oocytes | 4 | 1992 | 430 | 0.050 |
Why?
|
| Structure-Activity Relationship | 2 | 1994 | 964 | 0.050 |
Why?
|
| Topoisomerase II Inhibitors | 1 | 2001 | 56 | 0.050 |
Why?
|
| Thymidine Kinase | 1 | 2002 | 198 | 0.050 |
Why?
|
| Nucleic Acid Synthesis Inhibitors | 1 | 2001 | 47 | 0.050 |
Why?
|
| Hemoglobinuria | 1 | 2001 | 5 | 0.050 |
Why?
|
| Mass Spectrometry | 1 | 2004 | 717 | 0.050 |
Why?
|
| Prolapse | 1 | 2001 | 13 | 0.050 |
Why?
|
| Cell Differentiation | 3 | 2019 | 4163 | 0.050 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2017 | 5531 | 0.050 |
Why?
|
| Herpesvirus 1, Human | 1 | 2002 | 111 | 0.050 |
Why?
|
| Brain Neoplasms | 1 | 2018 | 4995 | 0.050 |
Why?
|
| Catalysis | 1 | 2001 | 250 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2018 | 4773 | 0.050 |
Why?
|
| Glomerulonephritis, Membranoproliferative | 1 | 2001 | 23 | 0.050 |
Why?
|
| Phosphodiesterase Inhibitors | 1 | 2001 | 68 | 0.050 |
Why?
|
| Oogenesis | 1 | 2001 | 71 | 0.050 |
Why?
|
| Cell Culture Techniques | 1 | 2004 | 595 | 0.050 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2021 | 220 | 0.050 |
Why?
|
| Acetylcysteine | 1 | 2002 | 147 | 0.050 |
Why?
|
| Lymphoid Tissue | 1 | 2001 | 96 | 0.050 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2001 | 96 | 0.050 |
Why?
|
| Primary Cell Culture | 1 | 2021 | 207 | 0.050 |
Why?
|
| Caffeine | 1 | 2001 | 91 | 0.050 |
Why?
|
| Glucose | 1 | 2007 | 1267 | 0.050 |
Why?
|
| Cricetinae | 3 | 1994 | 712 | 0.050 |
Why?
|
| Indoles | 1 | 2006 | 1021 | 0.050 |
Why?
|
| Proteinuria | 1 | 2001 | 163 | 0.050 |
Why?
|
| Proteasome Endopeptidase Complex | 1 | 2003 | 592 | 0.050 |
Why?
|
| Acetylation | 1 | 2021 | 521 | 0.050 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group M | 1 | 2020 | 5 | 0.050 |
Why?
|
| Hippocampus | 1 | 2006 | 937 | 0.040 |
Why?
|
| DNA, Recombinant | 3 | 2004 | 120 | 0.040 |
Why?
|
| Indicators and Reagents | 3 | 2004 | 133 | 0.040 |
Why?
|
| Hydroxymethylglutaryl-CoA Synthase | 1 | 2019 | 9 | 0.040 |
Why?
|
| Virus Replication | 3 | 2010 | 726 | 0.040 |
Why?
|
| Cell Compartmentation | 1 | 1999 | 79 | 0.040 |
Why?
|
| Intracellular Fluid | 1 | 1999 | 46 | 0.040 |
Why?
|
| Nitric Oxide Synthase | 1 | 2020 | 321 | 0.040 |
Why?
|
| Whole Genome Sequencing | 1 | 2021 | 350 | 0.040 |
Why?
|
| Lysine | 1 | 2021 | 428 | 0.040 |
Why?
|
| Sequence Deletion | 2 | 2017 | 880 | 0.040 |
Why?
|
| Cell Self Renewal | 1 | 2019 | 68 | 0.040 |
Why?
|
| Immune System | 1 | 2001 | 283 | 0.040 |
Why?
|
| Copper Radioisotopes | 1 | 2019 | 31 | 0.040 |
Why?
|
| HCT116 Cells | 1 | 2020 | 353 | 0.040 |
Why?
|
| Gallium Radioisotopes | 1 | 2019 | 60 | 0.040 |
Why?
|
| Molecular Weight | 3 | 1995 | 633 | 0.040 |
Why?
|
| Spermatogenesis | 1 | 2001 | 322 | 0.040 |
Why?
|
| DNA, Single-Stranded | 1 | 2019 | 106 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2004 | 3071 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 4 | 2017 | 5509 | 0.040 |
Why?
|
| Isotope Labeling | 1 | 2019 | 144 | 0.040 |
Why?
|
| Sf9 Cells | 1 | 2018 | 15 | 0.040 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2020 | 283 | 0.040 |
Why?
|
| tau Proteins | 2 | 2006 | 219 | 0.040 |
Why?
|
| Models, Molecular | 3 | 1998 | 1768 | 0.040 |
Why?
|
| Endoplasmic Reticulum-Associated Degradation | 1 | 2018 | 35 | 0.040 |
Why?
|
| Fertility | 1 | 2001 | 341 | 0.040 |
Why?
|
| Cytoskeletal Proteins | 2 | 1997 | 514 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-met | 1 | 2021 | 424 | 0.040 |
Why?
|
| Cell Adhesion | 1 | 2021 | 1016 | 0.040 |
Why?
|
| Glycosylation | 1 | 2018 | 219 | 0.040 |
Why?
|
| Chromatography, Ion Exchange | 2 | 1994 | 84 | 0.040 |
Why?
|
| Metabolomics | 1 | 2021 | 483 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 1998 | 338 | 0.040 |
Why?
|
| Biological Transport | 1 | 1999 | 605 | 0.040 |
Why?
|
| Green Fluorescent Proteins | 2 | 2015 | 701 | 0.040 |
Why?
|
| Mammary Glands, Animal | 1 | 2021 | 546 | 0.040 |
Why?
|
| Genetic Techniques | 1 | 2018 | 136 | 0.040 |
Why?
|
| Calcium-Binding Proteins | 1 | 2020 | 540 | 0.040 |
Why?
|
| ras Proteins | 1 | 2001 | 783 | 0.040 |
Why?
|
| Mammary Glands, Human | 1 | 2018 | 184 | 0.040 |
Why?
|
| BRCA2 Protein | 1 | 2019 | 374 | 0.040 |
Why?
|
| Pregnancy | 1 | 2010 | 7818 | 0.040 |
Why?
|
| Colon | 1 | 2001 | 677 | 0.040 |
Why?
|
| Calcium Signaling | 1 | 2019 | 292 | 0.040 |
Why?
|
| Young Adult | 2 | 2019 | 22098 | 0.040 |
Why?
|
| F-Box Proteins | 1 | 1997 | 102 | 0.040 |
Why?
|
| Neuropeptides | 1 | 1997 | 156 | 0.040 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 2 | 1999 | 1292 | 0.040 |
Why?
|
| Isoenzymes | 1 | 2019 | 633 | 0.030 |
Why?
|
| Osteoblasts | 1 | 2019 | 385 | 0.030 |
Why?
|
| Organ Specificity | 1 | 1998 | 702 | 0.030 |
Why?
|
| Xenopus laevis | 2 | 1994 | 275 | 0.030 |
Why?
|
| Gene Silencing | 1 | 2019 | 838 | 0.030 |
Why?
|
| Receptors, Notch | 1 | 2019 | 385 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2019 | 498 | 0.030 |
Why?
|
| Gene Expression Profiling | 2 | 2014 | 5239 | 0.030 |
Why?
|
| Oncogene Proteins | 1 | 2018 | 362 | 0.030 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2019 | 480 | 0.030 |
Why?
|
| Melanoma, Experimental | 1 | 2018 | 377 | 0.030 |
Why?
|
| Prognosis | 1 | 2014 | 22227 | 0.030 |
Why?
|
| RNA-Binding Proteins | 2 | 2020 | 1007 | 0.030 |
Why?
|
| Cell Extracts | 1 | 2015 | 62 | 0.030 |
Why?
|
| Glycoside Hydrolases | 1 | 2015 | 38 | 0.030 |
Why?
|
| Killer Cells, Natural | 1 | 2021 | 931 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2017 | 491 | 0.030 |
Why?
|
| Maturation-Promoting Factor | 2 | 1992 | 22 | 0.030 |
Why?
|
| Ranidae | 1 | 1994 | 4 | 0.030 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2019 | 620 | 0.030 |
Why?
|
| Retinoblastoma-Binding Protein 1 | 1 | 1994 | 52 | 0.030 |
Why?
|
| Transcription Factor DP1 | 1 | 1994 | 55 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 2 | 1992 | 261 | 0.030 |
Why?
|
| Neurons | 1 | 2006 | 2385 | 0.030 |
Why?
|
| Antibody Specificity | 1 | 1995 | 337 | 0.030 |
Why?
|
| Cross Reactions | 1 | 1995 | 271 | 0.030 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2001 | 1511 | 0.030 |
Why?
|
| Intestines | 1 | 2019 | 691 | 0.030 |
Why?
|
| Cytarabine | 1 | 2001 | 1993 | 0.030 |
Why?
|
| Chromatography, Affinity | 1 | 1994 | 122 | 0.030 |
Why?
|
| E2F Transcription Factors | 1 | 1994 | 131 | 0.030 |
Why?
|
| Restriction Mapping | 1 | 1994 | 266 | 0.030 |
Why?
|
| Poly (ADP-Ribose) Polymerase-1 | 1 | 2015 | 168 | 0.030 |
Why?
|
| RNA | 1 | 2020 | 1030 | 0.030 |
Why?
|
| Medication Adherence | 1 | 2019 | 521 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 1005 | 0.030 |
Why?
|
| Radiation Dosage | 1 | 2019 | 1025 | 0.030 |
Why?
|
| Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1993 | 208 | 0.030 |
Why?
|
| Myristic Acids | 2 | 1992 | 13 | 0.030 |
Why?
|
| Pyrazines | 1 | 2017 | 508 | 0.030 |
Why?
|
| Meiosis | 2 | 1992 | 172 | 0.030 |
Why?
|
| Germ-Line Mutation | 1 | 2019 | 1081 | 0.030 |
Why?
|
| COS Cells | 2 | 2006 | 387 | 0.030 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2015 | 318 | 0.030 |
Why?
|
| E2F1 Transcription Factor | 1 | 1994 | 197 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2017 | 1336 | 0.030 |
Why?
|
| Retinoblastoma-Like Protein p107 | 1 | 1993 | 5 | 0.030 |
Why?
|
| Viral Proteins | 2 | 2007 | 443 | 0.030 |
Why?
|
| Affinity Labels | 1 | 1993 | 28 | 0.030 |
Why?
|
| Swine | 2 | 1994 | 1610 | 0.030 |
Why?
|
| GTP-Binding Proteins | 1 | 2014 | 325 | 0.030 |
Why?
|
| Cell Movement | 1 | 2021 | 2498 | 0.030 |
Why?
|
| Ribosomal Protein S6 | 1 | 2012 | 47 | 0.030 |
Why?
|
| T-Lymphocytes, Cytotoxic | 1 | 2018 | 1018 | 0.030 |
Why?
|
| Positron Emission Tomography Computed Tomography | 1 | 2019 | 858 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1993 | 301 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2019 | 1158 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2021 | 4052 | 0.030 |
Why?
|
| Micronucleus Tests | 1 | 2012 | 19 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 1994 | 383 | 0.030 |
Why?
|
| Adult | 4 | 2019 | 80595 | 0.030 |
Why?
|
| NF-kappa B | 1 | 2019 | 1584 | 0.030 |
Why?
|
| Sequence Alignment | 3 | 1999 | 847 | 0.030 |
Why?
|
| Oligonucleotides | 1 | 1993 | 231 | 0.030 |
Why?
|
| Rats | 2 | 2006 | 6198 | 0.030 |
Why?
|
| MAP Kinase Kinase 4 | 1 | 2012 | 143 | 0.030 |
Why?
|
| Vanadates | 1 | 1991 | 21 | 0.020 |
Why?
|
| Organophosphorus Compounds | 1 | 1992 | 104 | 0.020 |
Why?
|
| DNA, Viral | 2 | 2004 | 674 | 0.020 |
Why?
|
| Nitrophenols | 1 | 1992 | 94 | 0.020 |
Why?
|
| Poly A | 1 | 1991 | 91 | 0.020 |
Why?
|
| Antibodies | 1 | 1994 | 842 | 0.020 |
Why?
|
| Chemotherapy, Adjuvant | 1 | 2019 | 3960 | 0.020 |
Why?
|
| Androstadienes | 1 | 2012 | 171 | 0.020 |
Why?
|
| Middle Aged | 3 | 2019 | 89422 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 1994 | 438 | 0.020 |
Why?
|
| Clinical Trials as Topic | 1 | 2021 | 3836 | 0.020 |
Why?
|
| Adenosine | 1 | 1993 | 294 | 0.020 |
Why?
|
| Adenosine Triphosphate | 1 | 1993 | 578 | 0.020 |
Why?
|
| Immunotherapy, Adoptive | 1 | 2021 | 1890 | 0.020 |
Why?
|
| Minichromosome Maintenance Complex Component 4 | 1 | 2010 | 2 | 0.020 |
Why?
|
| Minichromosome Maintenance Complex Component 2 | 1 | 2010 | 6 | 0.020 |
Why?
|
| Culture Media, Serum-Free | 1 | 2010 | 77 | 0.020 |
Why?
|
| Myristic Acid | 1 | 1990 | 10 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2002 | 5028 | 0.020 |
Why?
|
| Longevity | 1 | 2011 | 154 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2012 | 707 | 0.020 |
Why?
|
| Genes, Regulator | 1 | 1989 | 70 | 0.020 |
Why?
|
| Adenylate Kinase | 1 | 2009 | 35 | 0.020 |
Why?
|
| Suppression, Genetic | 1 | 1989 | 67 | 0.020 |
Why?
|
| Models, Genetic | 2 | 2005 | 1129 | 0.020 |
Why?
|
| Immunological Synapses | 1 | 2009 | 31 | 0.020 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2015 | 2258 | 0.020 |
Why?
|
| Methionine | 1 | 1990 | 161 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2015 | 3664 | 0.020 |
Why?
|
| Telophase | 1 | 2008 | 2 | 0.020 |
Why?
|
| Exons | 1 | 2012 | 1351 | 0.020 |
Why?
|
| Antigen Presentation | 1 | 2009 | 283 | 0.020 |
Why?
|
| Pyrazoles | 1 | 2017 | 1517 | 0.020 |
Why?
|
| Biomarkers, Tumor | 2 | 2017 | 10623 | 0.020 |
Why?
|
| Gene Dosage | 1 | 2011 | 839 | 0.020 |
Why?
|
| Aged | 2 | 2012 | 72807 | 0.020 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 7701 | 0.020 |
Why?
|
| Retinoblastoma | 1 | 1989 | 195 | 0.020 |
Why?
|
| Triazoles | 1 | 2012 | 630 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2011 | 518 | 0.020 |
Why?
|
| Nitriles | 1 | 2012 | 935 | 0.020 |
Why?
|
| Disease-Free Survival | 1 | 2019 | 10092 | 0.020 |
Why?
|
| Consensus Sequence | 2 | 1999 | 114 | 0.020 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 1990 | 2395 | 0.020 |
Why?
|
| Phenylalanine | 1 | 1987 | 150 | 0.020 |
Why?
|
| Eye Neoplasms | 1 | 1989 | 254 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2007 | 249 | 0.020 |
Why?
|
| Anemia | 1 | 2012 | 726 | 0.020 |
Why?
|
| Exome | 1 | 2012 | 1272 | 0.020 |
Why?
|
| Phosphoric Acids | 1 | 2006 | 3 | 0.020 |
Why?
|
| Leukemia, Monocytic, Acute | 1 | 1986 | 31 | 0.020 |
Why?
|
| Isomerism | 1 | 2006 | 63 | 0.020 |
Why?
|
| Nanotechnology | 1 | 2007 | 139 | 0.020 |
Why?
|
| Genes | 1 | 1987 | 478 | 0.020 |
Why?
|
| Alzheimer Disease | 1 | 1993 | 892 | 0.020 |
Why?
|
| Herpesviridae Infections | 1 | 2007 | 176 | 0.020 |
Why?
|
| Peptide Fragments | 2 | 2004 | 1294 | 0.020 |
Why?
|
| Chromatography, Liquid | 1 | 2007 | 356 | 0.020 |
Why?
|
| Viral Plaque Assay | 1 | 2004 | 48 | 0.010 |
Why?
|
| Skin | 1 | 2010 | 1283 | 0.010 |
Why?
|
| Mutagenesis | 2 | 1998 | 482 | 0.010 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2004 | 86 | 0.010 |
Why?
|
| Growth Substances | 1 | 2005 | 308 | 0.010 |
Why?
|
| Dimerization | 1 | 2004 | 311 | 0.010 |
Why?
|
| Histidine | 1 | 2004 | 93 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2012 | 2111 | 0.010 |
Why?
|
| Nocodazole | 1 | 2003 | 25 | 0.010 |
Why?
|
| STAT1 Transcription Factor | 1 | 2004 | 158 | 0.010 |
Why?
|
| Protein Conformation | 2 | 1998 | 1271 | 0.010 |
Why?
|
| Herpesvirus 4, Human | 1 | 2007 | 954 | 0.010 |
Why?
|
| Burkitt Lymphoma | 1 | 1985 | 344 | 0.010 |
Why?
|
| Alanine | 1 | 2003 | 247 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 2004 | 431 | 0.010 |
Why?
|
| Cdc20 Proteins | 1 | 2002 | 26 | 0.010 |
Why?
|
| Resting Phase, Cell Cycle | 1 | 2002 | 36 | 0.010 |
Why?
|
| Two-Hybrid System Techniques | 1 | 2002 | 182 | 0.010 |
Why?
|
| Diketopiperazines | 1 | 2001 | 7 | 0.010 |
Why?
|
| Embryo, Mammalian | 1 | 2005 | 749 | 0.010 |
Why?
|
| Ataxia Telangiectasia | 1 | 2001 | 63 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2003 | 649 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 302 | 0.010 |
Why?
|
| Tomography, Emission-Computed | 1 | 2002 | 324 | 0.010 |
Why?
|
| Treatment Outcome | 2 | 2012 | 34176 | 0.010 |
Why?
|
| Ultraviolet Rays | 1 | 1983 | 590 | 0.010 |
Why?
|
| Point Mutation | 1 | 2003 | 774 | 0.010 |
Why?
|
| Sirolimus | 1 | 2004 | 834 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2019 | 30768 | 0.010 |
Why?
|
| 1-Phosphatidylinositol 4-Kinase | 2 | 1990 | 18 | 0.010 |
Why?
|
| Leucine Zippers | 1 | 1999 | 39 | 0.010 |
Why?
|
| Pyrones | 1 | 1998 | 10 | 0.010 |
Why?
|
| Alkenes | 1 | 1998 | 12 | 0.010 |
Why?
|
| Kidney | 2 | 1985 | 2183 | 0.010 |
Why?
|
| Polyenes | 1 | 1998 | 34 | 0.010 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1998 | 118 | 0.010 |
Why?
|
| Nerve Tissue Proteins | 1 | 2006 | 1508 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 3 | 1 | 1997 | 3 | 0.010 |
Why?
|
| Cloning, Organism | 1 | 1997 | 6 | 0.010 |
Why?
|
| Disulfides | 1 | 1998 | 116 | 0.010 |
Why?
|
| Spectrum Analysis | 1 | 1998 | 141 | 0.010 |
Why?
|
| F-Box-WD Repeat-Containing Protein 7 | 1 | 1997 | 84 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2005 | 2084 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 5121 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 1998 | 644 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2002 | 2113 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 1997 | 403 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2006 | 6194 | 0.010 |
Why?
|
| Neuroblastoma | 1 | 2000 | 695 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase 5 | 1 | 1993 | 34 | 0.010 |
Why?
|
| Monocytes | 2 | 1989 | 785 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1997 | 620 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1994 | 242 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 1997 | 1497 | 0.010 |
Why?
|
| Fungal Proteins | 1 | 1994 | 256 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1994 | 539 | 0.010 |
Why?
|
| Aphidicolin | 1 | 1992 | 30 | 0.010 |
Why?
|
| Microtubules | 1 | 1993 | 267 | 0.010 |
Why?
|
| Phosphatidylinositol 4,5-Diphosphate | 1 | 1992 | 19 | 0.010 |
Why?
|
| Phosphatidylinositols | 1 | 1992 | 60 | 0.010 |
Why?
|
| Embryo, Nonmammalian | 1 | 1992 | 231 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 1992 | 366 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 1992 | 191 | 0.010 |
Why?
|
| Cycloheximide | 1 | 1991 | 99 | 0.010 |
Why?
|
| Phospholipids | 1 | 1992 | 179 | 0.010 |
Why?
|
| Central Nervous System | 1 | 1993 | 449 | 0.010 |
Why?
|
| Microinjections | 1 | 1990 | 93 | 0.010 |
Why?
|
| Genes, Retinoblastoma | 1 | 1990 | 88 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-myb | 1 | 1990 | 50 | 0.010 |
Why?
|
| Connexins | 1 | 1990 | 81 | 0.010 |
Why?
|
| Mammals | 1 | 1992 | 372 | 0.010 |
Why?
|
| Spermatozoa | 1 | 1992 | 319 | 0.010 |
Why?
|
| Blotting, Northern | 1 | 1990 | 698 | 0.010 |
Why?
|
| Cytosol | 1 | 1990 | 234 | 0.010 |
Why?
|
| Genes, myc | 1 | 1990 | 359 | 0.010 |
Why?
|
| Isoelectric Point | 1 | 1988 | 29 | 0.010 |
Why?
|
| Solubility | 1 | 1988 | 248 | 0.000 |
Why?
|
| Retinoblastoma Protein | 1 | 1989 | 333 | 0.000 |
Why?
|
| Codon | 1 | 1988 | 245 | 0.000 |
Why?
|
| Proto-Oncogenes | 1 | 1988 | 202 | 0.000 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 1988 | 157 | 0.000 |
Why?
|
| Biological Assay | 1 | 1988 | 175 | 0.000 |
Why?
|
| Mice, Inbred Strains | 1 | 1988 | 523 | 0.000 |
Why?
|
| Disease Susceptibility | 1 | 1989 | 546 | 0.000 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 1986 | 7062 | 0.000 |
Why?
|
| Adenosine Triphosphatases | 1 | 1988 | 438 | 0.000 |
Why?
|
| Lymphocyte Activation | 1 | 1990 | 1698 | 0.000 |
Why?
|
| Endothelium, Vascular | 1 | 1989 | 905 | 0.000 |
Why?
|
| Nucleic Acid Hybridization | 1 | 1982 | 539 | 0.000 |
Why?
|
| Brain | 1 | 1993 | 4189 | 0.000 |
Why?
|